Celanese Corp. (CE) received a Schedule 13G filing showing that Capital Research Global Investors beneficially owns 5,565,556 shares of Celanese common stock, representing 5.1% of the class as of December 31, 2025.
The filing states these shares are held in the ordinary course of business and not for the purpose of changing or influencing control of Celanese. Capital Research Global Investors reports sole voting and sole dispositive power over all 5,565,556 shares out of 109,504,894 shares believed to be outstanding.
Celanese Corporation director Kathryn Hill reported a routine equity compensation transaction. On January 1, 2026, she converted 1,808.351 shares of phantom stock into 1,808.351 shares of Celanese common stock at a price of $0 per share under the company’s 2008 Deferred Compensation Plan.
After this conversion, she directly held 16,808.48 shares of common stock and 1,140.519 phantom stock units. Each phantom stock unit represents the right to receive one share of common stock, payable in shares as provided by the deferred compensation plan.
Celanese Corporation reported that Director Scott M. Sutton resigned from its Board of Directors effective January 4, 2026. He stepped down because of the expected responsibilities and time commitment required for his new role as Chief Executive Officer of Rayonier Advanced Materials Inc. The company states that his resignation is not due to any disagreement with Celanese regarding its operations, policies, or practices.
The Board acknowledges Mr. Sutton’s numerous contributions during his tenure and extends well wishes for his new position. Celanese also issued a press release on January 6, 2026, to publicly announce his resignation.
Celanese Corporation reports that its wholly owned subsidiary Celanese US Holdings LLC has completed a registered debt offering of $600,000,000 of 7.000% Senior Notes due 2031 and $800,000,000 of 7.375% Senior Notes due 2034.
The notes are senior unsecured obligations of the issuer and are guaranteed on a senior unsecured basis by Celanese Corporation and, initially, certain subsidiary guarantors. Interest will be paid semi-annually in arrears on February 15 and August 15 of each year, beginning on August 15, 2026.
Net proceeds from the offering, together with available cash, will be used to repay borrowings under Celanese’s five-year term loan credit agreement due 2027, to fund previously announced and upsized cash tender offers for approximately $1.2 billion of existing 6.665% notes due 2027 and 6.850% notes due 2028, and for general corporate purposes, which may include repaying other outstanding indebtedness.
Celanese Corporation reported that on December 16, 2025 it issued a press release detailing the early results and increase in size of its previously announced cash tender offers for two series of senior notes. The company is conducting cash tender offers to purchase up to an aggregate principal amount of $946,106,000 of its 6.665% Senior Notes due 2027 and up to $254,000,000 of its 6.850% Senior Notes due 2028. The filing mainly updates investors on the status and enlarged maximum size of these debt repurchase transactions.
Celanese Corp’s CEO and President, who also serves as a director, increased his personal stake in the company through a recent stock purchase. On 12/10/2025, he acquired 3,800 shares of Celanese common stock in an open market transaction coded as a purchase at a price of $41.5899 per share. Following this transaction, he beneficially owned 70,448.703 shares directly and an additional 597.0315 shares indirectly through a 401(k) plan. The form was filed for one reporting person, reflecting continued alignment of the senior executive’s holdings with Celanese’s equity.
Celanese Corp insider Chuck Kyrish, the company’s SVP & CFO, reported an equity transaction involving 5,000 shares of Celanese common stock on December 9, 2025, at a weighted average price of about $41.03 per share. After this activity, he beneficially owned 10,914.476 shares directly. The filing notes that the shares were executed in multiple trades within a price range from $40.885 to $41.112, and that detailed trade-by-trade information is available from the reporting person upon request.
Celanese Corporation announced that its subsidiary Celanese US Holdings LLC entered into an underwriting agreement for a new senior notes offering. The Issuer agreed to sell $600,000,000 aggregate principal amount of 7.000% Senior Notes due 2031 and $800,000,000 aggregate principal amount of 7.375% Senior Notes due 2034. The transaction is being conducted through a registered public offering under an existing shelf registration statement on Form S-3, using a prospectus, a related prospectus supplement dated December 2, 2025, and a free writing prospectus filed on December 3, 2025.
Celanese Corporation announced that its wholly owned subsidiary Celanese US Holdings LLC has launched cash tender offers to buy back up to an aggregate principal amount of $1,000,000,000 of its outstanding senior notes. The offers target its 6.665% Senior Notes due 2027 and 6.850% Senior Notes due 2028.
The 2028 notes are subject to a series cap, limiting purchases of that issue to a maximum aggregate principal amount of $100,000,000. The tender offers are being made on the terms and conditions described in an Offer to Purchase dated December 2, 2025, and represent a step in managing the company’s outstanding debt profile and interest-bearing obligations.
Celanese Corp (CE) reported an equity award to Chief Accounting Officer Aaron M. McGilvray. On 11/17/2025, he acquired 2,980 time-based restricted stock units (RSUs) of Celanese common stock at a price of $0 as a compensatory grant. Each RSU represents the right to receive one share of common stock if vesting conditions are met.
The RSUs will vest, subject to continued employment, in two equal installments of 50% on November 17, 2026 and November 17, 2027. Following this grant, McGilvray beneficially owns 10,319.378 shares directly and 798.8018 shares indirectly through a 401(k) plan.